Geertrui Vanhove's Insider Trades & SAST Disclosures
Geertrui Vanhove's most recent trade in Surrozen Inc was a trade of 9,578 Common Stock done at an average price of $0.4 . Disclosure was reported to the exchange on Dec. 15, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Geertrui Vanhove.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Surrozen Inc | Geertrui Trudy Vanhove | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.41 per share. | 15 Dec 2022 | 9,578 | 32,412 | - | 0.4 | 3,927 | Common Stock |
| Surrozen Inc | Geertrui Trudy Vanhove | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Oct 2022 | 26,220 | 0 | - | - | Option (right to buy) | |
| Surrozen Inc | Geertrui Trudy Vanhove | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2022 | 26,220 | 26,220 | - | - | Option (right to buy) | |
| Surrozen Inc | Geertrui Trudy Vanhove | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2022 | 24,587 | 24,587 | - | - | Option (right to buy) | |
| Surrozen Inc | Geertrui Trudy Vanhove | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Oct 2022 | 24,587 | 0 | - | - | Option (right to buy) | |
| Surrozen Inc | Geertrui Trudy Vanhove | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2022 | 10,427 | 10,427 | - | - | Option (right to buy) | |
| Surrozen Inc | Geertrui Trudy Vanhove | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Oct 2022 | 10,427 | 0 | - | - | Option (right to buy) | |
| Surrozen Inc | Geertrui Trudy Vanhove | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2022 | 1,760 | 1,760 | - | - | Option (right to buy) | |
| Surrozen Inc | Geertrui Trudy Vanhove | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Oct 2022 | 1,760 | 0 | - | - | Option (right to buy) | |
| Surrozen Inc | Geertrui Trudy Vanhove | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 125,000 | 125,000 | - | - | Option Grant (right to buy) | |
| Surrozen Inc | Geertrui Vanhove | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2021 | 36,647 | 36,647 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges